New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 28, 2014
14:29 EDTHZNPVidara Therapeutics reports 17.6% stake in Horizon Pharma
News For HZNP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 29, 2015
17:50 EDTHZNPHorizon Pharma announces HSR waiting period expiration for Hyperion acquisition
Subscribe for More Information
April 27, 2015
07:02 EDTHZNPHorizon announces issuance of additional notice of allowance for Pennsaid 2%
Horizon Pharma announced it received a Notice of Allowance from the United States Patent and Trademark Office for U.S. patent application number 14/497,096, entitled "Diclofenac Topical Formulation" that covers Horizon's U.S. approved product PENNSAID 2% w/w. This Notice of Allowance concludes the substantive examination of the patent application and will result in the issuance of a U.S. patent after administrative processes are completed. The U.S. patent scheduled to issue from this application will expire in 2027. After issuance, Horizon plans to list the patent in the FDA's Approved Drug Products with Therapeutic Equivalence Evaluations, or Orange Book. This will be the ninth U.S. patent to be listed in the Orange Book for PENNSAID 2%.
06:19 EDTHZNPPharmceutical companies buy drugs and raises prices, WSJ reports
Subscribe for More Information
April 23, 2015
10:13 EDTHZNPHigh option volume stocks
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use